Cleared Dual Track

K173398 - Xpert Xpress Strep A (FDA 510(k) Clearance)

Apr 2018
Decision
177d
Days
Class 2
Risk

K173398 is an FDA 510(k) clearance for the Xpert Xpress Strep A. This device is classified as a Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System (Class II - Special Controls, product code PGX).

Submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on April 26, 2018, 177 days after receiving the submission on October 31, 2017.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.2680. An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients..

Submission Details

510(k) Number K173398 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2017
Decision Date April 26, 2018
Days to Decision 177 days
Submission Type Dual Track
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PGX — Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.2680
Definition An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients.